Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cystic fibrosis–related diabetes is caused by islet loss and inflammation
Nathaniel Hart, Radhika Aramandla, Gregory Poffenberger, et al.
JCI Insight (2018) Vol. 3, Iss. 8
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Cystic fibrosis
Michal Shteinberg, Iram Haq, Deepika Polineni, et al.
The Lancet (2021) Vol. 397, Iss. 10290, pp. 2195-2211
Closed Access | Times Cited: 484
Interpreting type 1 diabetes risk with genetics and single-cell epigenomics
Joshua Chiou, Ryan J. Geusz, Mei-Lin Okino, et al.
Nature (2021) Vol. 594, Iss. 7863, pp. 398-402
Open Access | Times Cited: 294
Use of human islets to understand islet biology and diabetes: progress, challenges and suggestions
Nathaniel Hart, Alvin C. Powers
Diabetologia (2018) Vol. 62, Iss. 2, pp. 212-222
Open Access | Times Cited: 133
Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis
Andrea Granados, Christine L. Chan, Katie Larson Ode, et al.
Journal of Cystic Fibrosis (2019) Vol. 18, pp. S3-S9
Open Access | Times Cited: 125
Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy
Andrea Kelly, Diva D. De León, Saba Sheikh, et al.
American Journal of Respiratory and Critical Care Medicine (2018) Vol. 199, Iss. 3, pp. 342-351
Open Access | Times Cited: 89
The Human Islet: Mini-Organ With Mega-Impact
John T. Walker, Diane C. Saunders, Marcela Briššová, et al.
Endocrine Reviews (2021) Vol. 42, Iss. 5, pp. 605-657
Open Access | Times Cited: 67
The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis
Kevin J. Scully, Peter Marchetti, Gregory S. Sawicki, et al.
Journal of Cystic Fibrosis (2021) Vol. 21, Iss. 2, pp. 258-263
Open Access | Times Cited: 61
PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy
Dave P. Nichols, Scott H. Donaldson, Carla A. Frederick, et al.
Journal of Cystic Fibrosis (2021) Vol. 20, Iss. 2, pp. 205-212
Open Access | Times Cited: 60
Genetic risk converges on regulatory networks mediating early type 2 diabetes
John T. Walker, Diane C. Saunders, Vivek Rai, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 621-629
Open Access | Times Cited: 29
Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status
Chenglin Hu, Yuan Chen, Xinpeng Yin, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Human islets expressing HNF1A variant have defective β cell transcriptional regulatory networks
Rachana Haliyur, Xin Tong, May Sanyoura, et al.
Journal of Clinical Investigation (2018) Vol. 129, Iss. 1, pp. 246-251
Open Access | Times Cited: 71
New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling
Alejandra Tomás, Ben Jones, Colin A. Leech
Journal of Molecular Biology (2019) Vol. 432, Iss. 5, pp. 1347-1366
Closed Access | Times Cited: 65
The Role of α-Cells in Islet Function and Glucose Homeostasis in Health and Type 2 Diabetes
Patrick Gilon
Journal of Molecular Biology (2020) Vol. 432, Iss. 5, pp. 1367-1394
Closed Access | Times Cited: 65
Effect of one-year lumacaftor–ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients
Bastien Misgault, Eva Chatron, Quitterie Reynaud, et al.
Journal of Cystic Fibrosis (2020) Vol. 19, Iss. 5, pp. 712-716
Open Access | Times Cited: 59
Effect of CFTR modulator therapy on cystic fibrosis-related diabetes
Holly Gaines, Kellie Jones, Jonea Lim, et al.
Journal of Diabetes and its Complications (2021) Vol. 35, Iss. 6, pp. 107845-107845
Open Access | Times Cited: 41
Cystic fibrosis-related diabetes and lung disease: an update
Bernadette Prentice, Adam Jaffé, Shihab A. Hameed, et al.
European Respiratory Review (2021) Vol. 30, Iss. 159, pp. 200293-200293
Open Access | Times Cited: 41
Exocrine-Endocrine Crosstalk: The Influence of Pancreatic Cellular Communications on Organ Growth, Function and Disease
Danielle Overton, Teresa L. Mastracci
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 34
ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis‐related diabetes in children and adolescents
Katie Larson Ode, Manfred Ballman, Alberto Battezzati, et al.
Pediatric Diabetes (2022) Vol. 23, Iss. 8, pp. 1212-1228
Open Access | Times Cited: 31
Short-Term Effects of Elexacaftor/Tezacaftor/Ivacaftor Combination on Glucose Tolerance in Young People With Cystic Fibrosis—An Observational Pilot Study
Insa Korten, Elisabeth Kieninger, Linn Krueger, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 29
Metabolic Syndrome and Tendon Disease: A Comprehensive Review
Canhao Lai, Ruichen Li, Weili Tang, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 1597-1609
Open Access | Times Cited: 6
Recent advances in developing therapeutics for cystic fibrosis
Lisa J. Strug, Anne L. Stephenson, Naim Panjwani, et al.
Human Molecular Genetics (2018) Vol. 27, Iss. R2, pp. R173-R186
Open Access | Times Cited: 54
Integrated human pseudoislet system and microfluidic platform demonstrate differences in GPCR signaling in islet cells
John T. Walker, Rachana Haliyur, Heather A. Nelson, et al.
JCI Insight (2020) Vol. 5, Iss. 10
Open Access | Times Cited: 48
Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients
Amir Moheet, Daniel Beisang, Lin Zhang, et al.
Journal of Cystic Fibrosis (2020) Vol. 20, Iss. 2, pp. 333-338
Open Access | Times Cited: 48
Imaging mass spectrometry enables molecular profiling of mouse and human pancreatic tissue
Boone M. Prentice, Nathaniel Hart, Neil Phillips, et al.
Diabetologia (2019) Vol. 62, Iss. 6, pp. 1036-1047
Open Access | Times Cited: 45
The supply chain of human pancreatic β cell lines
Raphaël Scharfmann, Willem Staels, Olivier Albagli
Journal of Clinical Investigation (2019) Vol. 129, Iss. 9, pp. 3511-3520
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top